Abstract
Multichannel transceiver coil arrays are needed to enable parallel imaging and B1 manipulation in ultrahigh field MR imaging and spectroscopy. However, the design of such transceiver coils and coil arrays often faces technical challenges in achieving the required high operating frequency at the ultrahigh fields and sufficient electromagnetic (EM) decoupling between resonant elements. In this work, we propose a high impedance microstrip transmission line resonator (HIMTL) technique that has unique high frequency capability and adequate EM decoupling without the use of dedicated decoupling circuits. To validate the proposed technique for the ultrahigh field 10.5T applications, a two-channel high impedance microstrip array with the element dimension of 8cm by 8cm was built and tuned to 447 MHz, Larmor frequency of proton at 10.5T, for signal excitation and reception. Bench tests and numerical simulations were performed to evaluate its feasibility and performance. The results show that the proposed high impedance microstrip technique can be a simple and robust way to design high frequency transceiver coils and coil arrays for ultrahigh field MR applications.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is supported in part by the NIH under a BRP grant U01 EB023829 and by the State University of New York (SUNY) under SUNY Empire Innovation Professorship Award.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
